Christopher Liu Stock Analyst Profile - LUCID CAPITAL MARKETS Research Coverage - Stocknear

Christopher Liu

Stock Analyst at LUCID CAPITAL MARKETS

(4.76)
# 788
Out of 5,497 analysts
8
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

7 Stocks

Name Action PT Current % Upside Ratings Updated
LYEL Lyell Immunopharma
Initiates Coverage On: Buy
20
15.36 30.21% 1 Sep 26, 2025
ADAG Adagene
Initiates Coverage On: Buy
9
2.04 341.18% 1 Sep 18, 2025
GNLX Genelux
Initiates Coverage On: Buy
10
4.31 132.02% 1 Jul 21, 2025
RLAY Relay Therapeutics
Maintains: Outperform
19 18
5.18 247.49% 1 Dec 4, 2024
IDYA IDEAYA Biosciences
Downgrades: Market Perform
41 27
27.66 -2.39% 2 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
42
84.88 -50.52% 1 Aug 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
18
41.04 -56.14% 1 Aug 8, 2023